Tuesday, March 4, 2025
HomeSchoolsUniversity of Florida Wins $3.5M to Research Opioid Treatment

University of Florida Wins $3.5M to Research Opioid Treatment

-

The University of Florida has received a $3.5 million grant from the National Institute on Drug Abuse to research the use of kratom to treat opioid misuse.

The university’s College of Pharmacy won the grant for its earlier research on kratom, which comes from the leaves of a tropical tree from Southeast Asia.

The new study will be led by Lance McMahon, Ph.D., chair of the college’s department of pharmacodynamics, and Professor Chris McCurdy, who will focus on identifying pharmacology of its 40 alkaloids and test them for their effectiveness in quitting the use of opioids.

“Chris McCurdy was a pioneer in the area of kratom research 10 years ago,” McMahon said. “This NIDA grant shows interest in the potential of kratom-based medicines, as well as concerns over the potentialmisuse of kratom-related substances.”

The university’s team of researchers are further working on developing different treatment strategies to help people quit the use of opioids.

Last month, Facebook collaborated with the University of Alabama in Birmingham to counter the latest tactics used online to promote and sell drugs. According to the social media giant, the university’s research lab will lead the efforts in understanding the patternused by “bad actors” online to “mask their activity.”

You Might Also Like

Latest Posts

Medical School After 30: Should You Do It?

Considering making the jump to medical school after 30 years old? Take inspiration from those who took the leap and see the road ahead on what to expect towards that MD.

What Do I Need to Fill Out the FAFSA? Your Federal Aid Checklist

There are so many things you need to fill out the FAFSA. If you don't know where to start, this checklist can help you out.

14 Trade School Subjects That’ll Get You a High-Paying Career

If you’re not sure what career path to pursue, here are 14 of the best trade school subjects for 2021 and beyond.